U.S. Specialized REITs Stock News

Tariffs on Canadian imports and higher taxes on generic drugs are shaking up expectations for costs and pricing across healthcare. For U.S. specialty pharmaceutical manufacturers, this mix of pressure and opportunity can be important. Some companies may face higher input costs. Others with more domestic production may see a relative edge if imported generics become more expensive. This article explains how the new trade measures could matter for your portfolio and discusses 3 U.S. specialty...

Last week saw the newest quarterly earnings release from BigBear.ai Holdings, Inc. ( NYSE:BBAI ), an important...

RBC Bearings Incorporated has reported its fiscal first-quarter 2027 results, with net sales rising to US$519.5 million and net income to US$101.5 million, and has issued second-quarter guidance calling for net sales between US$505.0 million and US$515.0 million, implying double-digit year-over-year growth. The combination of strong Aerospace & Defense demand, broad-based Industrial segment growth, and guidance that points to continued operational momentum highlights how current end-market...

It's been a good week for The Baldwin Insurance Group, Inc. ( NASDAQ:BWIN ) shareholders, because the company has just...

Check Point Software Technologies Ltd. ( NASDAQ:CHKP ) shareholders are probably feeling a little disappointed, since...

Tariffs on Canadian dairy, alcohol, and autos are reshaping expectations for cross border trade, and that puts the spotlight on U.S. Domestic Manufacturing stocks with direct or indirect exposure to this news. The new 50% tariffs and the risk of retaliation could shift where goods are produced, how supply chains are structured, and which companies gain or lose pricing power. This article looks at three stocks from the U.S. Domestic Manufacturing screener that appear to be positively exposed...

The latest Federal Reserve meeting kept interest rates on hold but still triggered the Dow’s worst single-session drop in over a year and exposed rare internal division at the FOMC. With inflation at 4.2% and pressure building on long-term Treasury yields, many investors are reassessing how much risk they want to carry in rate sensitive areas of the market. This article looks at three dividend paying stocks from our Defensive Dividend Stocks screener that appear closely tied to these cross...

The latest merger speculation swirling around AstraZeneca and Bristol Myers Squibb has pushed large cap pharma stocks back into the spotlight. Sharp price moves, including AstraZeneca’s intraday fall of up to 7% and a 6% premarket jump for Bristol Myers, show how quickly sentiment can shift when potential mega deals hit the headlines. For investors, this kind of disruption can surface both opportunities and risks. This article looks at 3 stocks from a Healthcare screener that are exposed to...

The United States market remained flat over the last week but has shown an impressive 18% rise over the past 12 months, with earnings forecasted to grow by 16% annually. In this context, identifying stocks that are potentially undervalued can be crucial for investors seeking opportunities in a dynamic market environment.

In the last week, the United States market has remained flat, yet it has risen by 18% over the past year with anticipated earnings growth of 16% per annum in the coming years. In this environment, identifying stocks that are trading below their intrinsic value can offer potential opportunities for investors seeking to capitalize on undervaluation.

The United States market remained flat over the last week but has seen an 18% increase over the past year, with earnings forecasted to grow by 16% annually. In such a landscape, growth companies with high insider ownership can be appealing as they often indicate strong confidence from those closest to the business and potential for robust performance.

The market remained flat over the last week, but over the past 12 months, it has risen 18%, with earnings forecast to grow by 16% annually. Investing in penny stocks—though a somewhat outdated term—still highlights opportunities in smaller or newer companies that can offer great value. By focusing on those with robust financials and a clear growth trajectory, investors can find promising opportunities among these lesser-known stocks.

The United States market has experienced a flat week but has seen an impressive 18% rise over the past year, with earnings projected to grow by 16% annually. In this environment, identifying stocks with strong fundamentals and growth potential can be key to uncovering promising opportunities.

The United States market remained flat over the last week but has seen an impressive 18% rise over the past year, with earnings projected to grow by 16% annually. In this context, dividend stocks can be a valuable addition to portfolios, offering potential income and stability amidst fluctuating market conditions.

XBP Global Holdings, Inc. ( NASDAQ:XBP ) is possibly approaching a major achievement in its business, so we would like...

Agree Realty Corporation recently reported its second-quarter and first-half 2026 results, showing year-on-year increases in sales, revenue and net income, with second-quarter revenue reaching US$205.10 million and net income US$54.65 million. An interesting takeaway is that while net income grew meaningfully, diluted earnings per share from continuing operations in the quarter edged up only slightly to US$0.44, highlighting the impact of a growing share count on per-share performance. Next,...

It's been a good week for Veralto Corporation ( NYSE:VLTO ) shareholders, because the company has just released its...

Despite the fact that Vertical Aerospace Ltd.'s (NYSE:EVTL) value has dropped 10% in the last week insiders who sold...

There's been a notable change in appetite for Meridian Holdings Inc. ( NASDAQ:MRDN ) shares in the week since its...

As you might know, The Hershey Company ( NYSE:HSY ) just kicked off its latest quarterly results with some very strong...

Why Apogee Therapeutics Stock Is On Investors’ Radar Apogee Therapeutics (APGE) recently attracted attention after its strong past 3 months return, which contrasts with relatively flat moves over the past week and month. Investors are weighing that performance against its current clinical stage profile. See our latest analysis for Apogee Therapeutics. At a latest share price of US$134.09, Apogee Therapeutics has seen share price momentum cool in the very short term. However, its 90 day share...

The Morning Bull - US Market Morning Update Monday, Aug, 3 2026 US stock futures are pointing higher this morning, with S&P 500 contracts up around 0.6%. The move comes as US 10 year Treasury yields hover near 4.7% to 4.8%, which keeps borrowing costs for mortgages, credit cards and corporate debt relatively expensive as the Federal Reserve talks tough on inflation. At the same time, a key consumer confidence survey from Michigan sits at 55.2 for July, a five month high, and one year...

First National Bank Alaska stock barely flinched after earnings, with the share price essentially flat. This suggests investors saw nothing to force a rethink of the long term thesis. The bank that markets know for steady profitability again reported double digit trailing earnings growth and a net profit margin in the high 30s. That combination keeps the core story intact. The real tension for you as an investor now lies between that earnings power and a stock that trades at a P/E of 12.7x...

Service Corporation International (SCI) has come into focus after reporting second quarter 2026 results that modestly exceeded market expectations, with management reaffirming full year earnings guidance and raising its adjusted operating cash flow midpoint. See our latest analysis for Service Corporation International. The latest earnings report has coincided with a clear pick up in interest in Service Corporation International, with an 11.65% year to date share price return and a 46.24%...